A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS)

BACKGROUND: Cognitive impairment is common in patients with multiple sclerosis (MS). Accurate and repeatable measures of cognition have the potential to be used as markers of disease activity. METHODS: We developed a 5-min computerized test to measure cognitive dysfunction in patients with MS. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaligh-Razavi, Seyed-Mahdi, Sadeghi, Maryam, Khanbagi, Mahdiyeh, Kalafatis, Chris, Nabavi, Seyed Massood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236354/
https://www.ncbi.nlm.nih.gov/pubmed/32423386
http://dx.doi.org/10.1186/s12883-020-01736-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236354/
https://www.ncbi.nlm.nih.gov/pubmed/32423386
http://dx.doi.org/10.1186/s12883-020-01736-x

Ejemplares similares